Welltower (NYSE:WELL – Get Free Report) had its price objective raised by research analysts at Scotiabank from $133.00 to $142.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the real estate investment trust’s stock. Scotiabank’s price target indicates a potential upside of 4.60% from the stock’s current price.
WELL has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Welltower from $115.00 to $137.00 and gave the company a “buy” rating in a research report on Wednesday, August 21st. Wolfe Research upgraded Welltower to a “strong-buy” rating in a research report on Friday, August 9th. Royal Bank of Canada lifted their price objective on Welltower from $101.00 to $114.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. StockNews.com raised shares of Welltower from a “sell” rating to a “hold” rating in a report on Wednesday, October 30th. Finally, Evercore ISI lifted their price target on shares of Welltower from $106.00 to $114.00 and gave the company an “in-line” rating in a report on Monday, September 16th. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $117.50.
Check Out Our Latest Research Report on WELL
Welltower Stock Performance
Welltower (NYSE:WELL – Get Free Report) last posted its earnings results on Monday, October 28th. The real estate investment trust reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.31). The firm had revenue of $2.06 billion during the quarter, compared to the consensus estimate of $1.95 billion. Welltower had a net margin of 12.22% and a return on equity of 3.20%. The firm’s revenue was up 23.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.92 EPS. As a group, research analysts predict that Welltower will post 4.3 earnings per share for the current year.
Institutional Investors Weigh In On Welltower
A number of hedge funds have recently made changes to their positions in the company. Quadrature Capital Ltd purchased a new stake in Welltower during the first quarter valued at $768,000. Lazard Asset Management LLC lifted its holdings in shares of Welltower by 43.7% in the 1st quarter. Lazard Asset Management LLC now owns 8,523 shares of the real estate investment trust’s stock valued at $795,000 after acquiring an additional 2,591 shares during the last quarter. Waverly Advisors LLC grew its position in Welltower by 11.0% in the first quarter. Waverly Advisors LLC now owns 11,706 shares of the real estate investment trust’s stock worth $1,094,000 after acquiring an additional 1,161 shares in the last quarter. B. Riley Wealth Advisors Inc. increased its stake in Welltower by 5.5% during the first quarter. B. Riley Wealth Advisors Inc. now owns 34,439 shares of the real estate investment trust’s stock worth $3,218,000 after acquiring an additional 1,798 shares during the last quarter. Finally, California State Teachers Retirement System raised its position in Welltower by 5.6% during the first quarter. California State Teachers Retirement System now owns 858,253 shares of the real estate investment trust’s stock valued at $80,195,000 after purchasing an additional 45,321 shares during the period. 94.80% of the stock is currently owned by hedge funds and other institutional investors.
Welltower Company Profile
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
Featured Stories
- Five stocks we like better than Welltower
- Dividend Capture Strategy: What You Need to Know
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- How to invest in marijuana stocks in 7 steps
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Are Dividend Challengers?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.